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The sigma-1 receptor is widely distributed in the central nervous system and periphery. Originally mischaracterized as an opioid receptor, the sigma-1 receptor binds a vast number of synthetic compounds but does not bind opioid peptides; it is currently considered an orphan receptor. The sigma-1 receptor pharmacophore includes an alkylamine core, also found in the endogenous compound N,N-dimethyltryptamine (DMT). DMT acts as a hallucinogen, but its receptor target has been unclear. DMT bound to sigma-1 receptors and inhibited voltage-gated sodium ion (Na + ) channels in both native cardiac myocytes and heterologous cells that express sigma-1 receptors. DMT induced hypermobility in wild-type mice but not in sigma-1 receptor knockout mice. These biochemical, physiological, and behavioral experiments indicate that DMT is an endogenous agonist for the sigma-1 receptor.
T he sigma-1 receptor binds a broad range of synthetic compounds (1) . It has long been suspected that the sigma-1 receptor is targeted by endogenous ligands, and several candidates have been proposed (2, 3) . Although progesterone and other neuroactive steroids are known to bind sigma-1 receptors and regulate some of their functions (1, 4), they do not exhibit agonist properties on sigma-1-regulated ion channels in electrophysiological experiments (5) .
Our search for a sigma receptor endogenous ligand (or ligands) was based on a variant of the canonical sigma-1 receptor ligand pharmacophore (6), but with a more basic structure (Fig. 1A) . Otherwise dissimilar sigma-1 receptor ligands possess a common N-substituted pharmacophore (Fig. 1A ): an N,N-dialkyl or N-alkyl-N-aralkyl product, most easily recognized in the high-affinity sigma-1 receptor ligand, fenpropimorph (7) . Similar chemical backbones can be derived from other sigma-1 receptor ligands such as haloperidol and cocaine (Fig. 1A) . N-substituted trace amines harbor this sigma-1 receptor ligand pharmacophore, but their interactions with sigma receptors have not been determined. Of particular interest is the only known endogenous mammalian N,N-dimethylated trace amine, N,N-dimethyltryptamine (DMT) (8) (9) (10) . In addition to being one of the active compounds in psychoactive snuffs (yopo, epená) and sacramental teas (ayahuasca, yagé) used in native shamanic rituals in South America, DMT can be produced by enzymes in mammalian lung (11) and in rodent brain (12) . DMT has been found in human urine, blood, and cerebrospinal fluid (9, 13) . Although there are no conclusive quantitative studies measuring the abundance of endogenous DMT because of its rapid metabolism (14) , DMT concentrations can be localized and elevated in certain instances. Evidence suggests that DMT can be locally sequestered into brain neurotransmitter storage vesicles and that DMT production increases in rodent brain under environmental stress (8) . Although a family of heterotrimeric GTP-binding protein (G protein)-coupled receptors (GPCRs) known as the trace amine receptors (TARs) was discovered in 2001 (15) , only two members of this family respond to trace amines and have been renamed trace amine-associated receptors (TAARs) (16) . Because other binding targets for trace amines and DMT are likely (8), we first examined the sigma-1 receptor binding affinities of the trace amines and their N-methylated and N,N-dimethylated counterparts.
Competition assays against the sigma-1 receptorspecific ligand, (+)-[ dimethylation of tryptamine and phenethylamine decreased sigma-2 receptor affinity (Fig. 1C) .
We tested the ability of tryptamine, N-methyltryptamine, and DMT to block sigma receptor photolabeling in rat liver homogenates by two radioactive photoaffinity labels, the sigma-1 receptorspecific cocaine derivative 3-[ (17) (Fig. 2A) (18) (Fig. 2B ). Both of these compounds have been used to identify the drug binding region of the sigma-1 receptor (18, 19) . As anticipated, [ (17)] photolabeling of the 26-kD sigma-1 receptor ( Fig. 2A) was protected best by DMT, with 61% protection by 50 mM DMT and almost 100% protection by 100 mM DMT. By contrast, tryptamine (Fig. 2B ).
An important biological activity of sigma receptor activation is the inhibition of ion channels, which operates through protein-protein interactions without mediation by G proteins and protein kinases (20) (21) (22) . In addition to modulating various types of voltage-activated K + channels (21, 23, 24) , the sigma-1 receptor associates with the Kv1.4 K + channel in posterior pituitary nerve terminals, as well as in Xenopus oocytes (22) . Sigma receptor ligands also modulate N-, L-, P/Q-, and R-type Ca 2+ channels in rat sympathetic and parasympathetic neurons (25) . Sigma receptor ligands modulate cardiac voltage-gated Na + channels (hNav1.5) in human embryonic kidney 293 (HEK293) cells, COS-7 cells, and neonatal mouse cardiac myocytes (26) . To evaluate the capacity of DMT to induce physiological responses by binding to sigma receptors, we examined the action of DMTon voltageactivated Na + current. Patch-clamp recordings from HEK293 cells stably expressing the human cardiac Na + channel hNav1.5 revealed voltage-activated Na + currents (I Na ) in response to voltage steps from -80 to -10 mV (Fig. 3B) . Application of 100 mM DMT inhibited I Na by 62 T 3% (n = 3 HEK293 cells), which reversed upon DMT removal. With hNav1.5 transiently transfected into COS-7 cells, 100 mM DMT inhibited I Na by only 22 T 4% (n = 3 COS-7 cells), but photolabeling has shown that these cells have much lower concentrations of endogenous sigma-1 receptors compared to HEK293 cells ( fig. S1 and Fig. 3B) . The difference between DMT inhibition of I Na in HEK293 and COS-7 cells (Fig. 3B , P < 0.03) thus demonstrates the dependence of I Na inhibition on sigma-1 receptors. Experiments in cardiac myocytes demonstrated the same DMT action in a native preparation (Fig.  3C) and enabled further demonstration of sigma-1 receptor dependence by using a sigma-1 receptor DMT. Average inhibition by DMT was determined by measuring peak I Na . Bars represent mean T SEM (n = 3 cells). I Na inhibition in HEK293 cells differed significantly from that in COS-7 cells (*P < 0.03). (C) Examples of I Na evoked as described in (B) in neonatal cardiac myocytes from WT and KO mice in the absence (control, black), presence (DMT, red), and after wash out (recovery, blue) of 100 mM DMT. Current inhibition in WT was significantly different from that in KO (*P < 0.002, n = 7 neonatal cardiac myocytes). (27) 
indeed showed the absence of sigma-1 receptor (26 kD) in the KO samples (Fig. 3A) . In WT neonatal cardiac myocytes, 100 mM DMT reversibly inhibited I Na by 29 T 3% (n = 7 WT myocytes), whereas I Na was reduced by only 7 T 2% (n = 7 KO myocytes) in KO myocytes (Fig. 3C, P < 0.002) .
Both DMT and sigma receptor ligands influence animal behavior. DMT injection induces hypermobility in rodents concurrently treated with the monoamine oxidase inhibitor pargyline (28) , and this action is not antagonized by blockers of dopamine or serotonin receptors, but is potently inhibited by haloperidol (28) . Although haloperidol is thought to act in part through the dopamine D 2 receptor system, it is also a potent sigma-1 receptor agonist [sigma-1 inhibition constant (K i ) = 3 nM (29); sigma-2 K i = 54 nM (29)] when inhibiting voltage-gated ion channels (5, 25) . Haloperidol reduces brain concentrations of DMT (8) and DMT inhibits haloperidol binding in brain tissue more robustly than the dopamine agonist apomorphine (8) . On the basis of these findings, which were discovered before sigma receptor identification, DMT has been hypothesized to act through an unknown "hallucinogen" receptor (8) . We confirmed results (28) that intraperitoneal (ip) administration of DMT (2 mg per kilogram of body weight) 2 hours after pargyline (75 mg/kg, ip) injection induced hypermobility in WT mice (7025 T 524.1 cm, n = 12 WT mice) in an open-field assay. Identical drug treatments in sigma-1 receptor KO mice had no hypermobility action (2328 T 322.9 cm, n = 12 KO mice, P < 0.0001; Fig. 4, A and B) . This result is particularly important to our understanding of sigma-1 receptor biological function because the KO mice are viable and fertile (27) . The sigma-1 receptor dependence of DMT-induced hypermobility parallels that induced by the sigma-1 receptor ligand (+)-SKF10047 in WT but not in KO mice (27) . As a positive control, methamphetamine, which is thought to act through catecholaminergic systems, induced hypermobility in both WT and KO mice (3 mg/kg, ip, n = 6 mice; Fig. 4 , B and C) with a reduced onset rate compared with that seen for DMT (Fig. 4, A and C) . This indicates that behavioral actions of DMT depend on the sigma-1 receptor, which may provide an alternative research area for psychiatric disorders that have not been linked to dopamine or N-methyl-Daspartate systems.
The binding, biochemical, physiological, and behavioral studies reported here all support the hypothesis that DMT acts as a ligand for the sigma-1 receptor. On the basis of our binding results and the sigma-1 receptor pharmacophore, endogenous trace amines and their N-methyl and N,N-dimethyl derivatives are likely to serve as endogenous sigma receptor regulators. Moreover, DMT, the only known mammalian N,N-dimethylated trace amine, can activate the sigma-1 receptor to modulate Na + channels. The recent discovery that the sigma-1 receptor functions as a molecular chaperone (30) may be relevant, because sigma-1 receptors, which are observed in the endoplasmic reticulum, associate with plasma membrane Kv 1.4 channels (22) and may serve as a molecular chaperone for ion channels. Furthermore, the behavioral effect of DMT may be due to activation or inhibition of sigma-1 receptor chaperone activity instead of, or in addition to, DMT/sigma-1 receptor modulation of ion channels. These studies thus suggest that this natural hallucinogen could exert its action by binding to sigma-1 receptors, which are abundant in the brain (1, 27) . This discovery may also extend to N,Ndimethylated neurotransmitters such as the psychoactive serotonin derivative N,N-dimethylserotonin (bufotenine), which has been found at elevated concentrations in the urine of schizophrenic patients (10) . The finding that DMT and sigma-1 receptors act as a ligand-receptor pair provides a long-awaited connection that will enable researchers to elucidate the biological functions of both of these molecules. We often evaluate the self and others from social comparisons. We feel envy when the target person has superior and self-relevant characteristics. Schadenfreude occurs when envied persons fall from grace. To elucidate the neurocognitive mechanisms of envy and schadenfreude, we conducted two functional magnetic resonance imaging studies. In study one, the participants read information concerning target persons characterized by levels of possession and self-relevance of comparison domains. When the target person's possession was superior and self-relevant, stronger envy and stronger anterior cingulate cortex (ACC) activation were induced. In study two, stronger schadenfreude and stronger striatum activation were induced when misfortunes happened to envied persons. ACC activation in study one predicted ventral striatum activation in study two. Our findings document mechanisms of painful emotion, envy, and a rewarding reaction, schadenfreude.
E nvy is one of the seven biblical sins, the Shakespearian "green-eyed monster," and what Bertrand Russell (1) called an unfortunate facet of human nature. It is an irrational, unpleasant feeling and a "painful emotion" (2) characterized by feelings of inferiority and resentment produced by an awareness of another's superior quality, achievement, or possessions (3). Understanding envy is important because of its broad implications, ranging from individual matwww.sciencemag.org SCIENCE VOL 323 13 FEBRUARY 2009 
